Journals / Retina-Vitreus / 2022 / Cilt: 31 - Sayı: 1

Systemic Vascular Endothelial Function in Patients with Central Retinal Vein Occlusion

Pages
9–14
Publication Date
2022-10-17
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: Our findings indicate that systemic endothelial dysfunction may be associated with CRVO.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Purpose: The aim of our study was to evaluate peripheral vascular endothelial function in patients with central retinal vein occlusion (CRVO) by measuring flow-mediated dilatation (FMD).
📊
Key Findings & Data:Materials and Methods: Our sample included 28 patients with CRVO (Group 1), 31 patients with systemic hypertension (Group 2) but no other systemic or ocular disease, and 29 age- and sex-matched healthy volunteers (Group 3).
💡
Conclusion & Impact:Conclusion: Our findings indicate that systemic endothelial dysfunction may be associated with CRVO.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Purpose: The aim of our study was to evaluate peripheral vascular endothelial function in patients with central retinal vein occlusion (CRVO) by measuring flow-mediated dilatation (FMD). Materials and Methods: Our sample included 28 patients with CRVO (Group 1), 31 patients with systemic hypertension (Group 2) but no other systemic or ocular disease, and 29 age- and sex-matched healthy volunteers (Group 3). We excluded participants with diabetes mellitus, cardiovascular disease, dyslipidemia, renal dysfunction, or a smoking habit. A cardiologist assessed the responses of endothelial function in all participants by measuring the FMD following brachial artery occlusion. Results: In Doppler measurements of the brachial artery, the brachial artery FMD value was 5.7±2.2 % in Group 1, 7.9±3.1 % in Group 2, and 15.6±7.9 % in Group 3. The arterial FMD values were significantly lower in patients with CRVO compared with healthy and hypertensive groups (p < 0.001 and p = 0.004, respectively). Conclusion: Our findings indicate that systemic endothelial dysfunction may be associated with CRVO.

🔖

Cite This Article

Altunel, O., Arifoglu, H. B., Özkan, E., Altunel, E., Duru, N., Ata, M. (2022). Systemic Vascular Endothelial Function in Patients with Central Retinal Vein Occlusion. Retina-Vitreus, Cilt: 31 - Sayı: 1, 9–14. https://ajindex.com/articles/589033

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Cugati S, Wang JJ, Rochtchina E, et al. Ten-year incidence of retinal vein occlusion in an older population: the Blue Mountains Eye Study. Arch Ophthalmol 2006;124:726-32
  2. Rogers S, McIntosh RL, Cheung N, et al. International Eye Disease Consortium. The prevalence of retinal vein occlusion: pooled data from population studies from the United States, Europe, Asia, and Australia. Ophthalmology 2010;117:313-9
  3. Stem MS, Talwar N, Comer GM, et al. A longitudinal analysis of risk factors associated with central retinal vein occlusion. Ophthalmology 2013;120:362-70
  4. Eye Disease Case-Control Study Group. Risk factors for central retinal vein occlusion. Arch Ophthalmol 1996;114:545-54
  5. Shahsuvaryan ML, Melkonyan AK. Central retinal vein occlusion risk profile: a case-control study. Eur J Ophthalmol 2003;13:445-52
  6. Hayreh SS, Zimmerman B, McCarthy MJ, et al. Systemic diseases associated with various types of retinal vein occlusion. Am J Ophthalmol 2001;131:61-77
  7. O’Mahoney PR, Wong DT, Ray JG. Retinal vein occlusion and traditional risk factors for atherosclerosis. Arch Ophthalmol 2008;126:692-9
  8. Kuo JZ, Lai CC, Ong FS, et al. Central retinal vein occlusion in a young Chinese population: risk factors and associated morbidity and mortality. Retina 2010;30:479-84
  9. Cheung N, Klein R, Wang JJ, et al. Traditional and novel cardiovascular risk factors for retinal vein occlusion: the Multiethnic Study of Atherosclerosis. Invest Ophthalmol Vis Sci 2008;49:4297-302
  10. Kuhli-Hattenbach C, Scharrer I, Luchtenberg M, et al. Coagulation disorders and the risk of retinal vein occlusion. Thromb Haemost 2010;103:299-305
  11. Wong TY, Larsen EK, Klein R, et al. Cardiovascular risk factors for retinal vein occlusion and arteriolar emboli: the Atherosclerosis Risk in Communities and Cardiovascular Health studies. Ophthalmology 2005;112:540-7
  12. Klein R, Moss SE, Meuer SM, et al. The 15-year cumulative incidence of retinal vein occlusion: the Beaver Dam Eye Study. Arch Ophthalmol 2008;126:513-8
  13. Green W.R., Chan C.C., Hutchins G.M., et al. Central retinal vein occlusion: a prospective histopathologic study of 29 eyes in 28 cases. Trans Am Ophthalmol Soc 1981;79: 371-422
  14. Vane JR, Anggard EE, Botting RM. Regulatory functions of the vascular endothelium. N Engl J Med 1990;323: 27-36
  15. Verma S, Anderson TJ. Fundamentals of endothelial function for the clinical cardiologist. Circulation 2002;105: 546-9
  16. Ras RT, Streppel MT, Draijer R, et al. Fl